Literature DB >> 11599733

Cytokines, chemokines and other effector molecules involved in meningococcal disease.

S J Hackett1, A P J Thomson1, C A Hart1.   

Abstract

This review examines the role of cytokines and chemokines in the pathogenesis of meningococcal disease (MCD) and draws comparisons with studies of other forms of sepsis in adults and in animal models. There are many similarities but also discrepancies between these data. MCD is a well-defined clinical syndrome with identifiable onset and time of presentation. It is a reliable model in which to study cytokine and chemokine responses in bacterial sepsis. Such studies may lead to new adjunctive treatments, which can be tested to ameliorate severe MCD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11599733     DOI: 10.1099/0022-1317-50-10-847

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

Review 1.  Meningococcal disease and its management in children.

Authors:  C Anthony Hart; Alistair P J Thomson
Journal:  BMJ       Date:  2006-09-30

2.  Stages of meningococcal sepsis simulated in vitro, with emphasis on complement and Toll-like receptor activation.

Authors:  Bernt Christian Hellerud; Jørgen Stenvik; Terje Espevik; John D Lambris; Tom Eirik Mollnes; Petter Brandtzaeg
Journal:  Infect Immun       Date:  2008-06-30       Impact factor: 3.441

3.  The structure of Neisseria meningitidis lipid A determines outcome in experimental meningococcal disease.

Authors:  Floris Fransen; Hendrik Jan Hamstra; Claire J Boog; Jos P van Putten; Germie P J M van den Dobbelsteen; Peter van der Ley
Journal:  Infect Immun       Date:  2010-05-03       Impact factor: 3.441

4.  Inhibition of inducible nitric oxide controls pathogen load and brain damage by enhancing phagocytosis of Escherichia coli K1 in neonatal meningitis.

Authors:  Rahul Mittal; Ignacio Gonzalez-Gomez; Kerstin A Goth; Nemani V Prasadarao
Journal:  Am J Pathol       Date:  2010-01-21       Impact factor: 4.307

5.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

6.  Molecular studies of meningococcal and pneumococcal meningitis patients in Ethiopia.

Authors:  Wude Mihret; Berit Sletbakk Brusletto; Reidun Øvstebø; Anne-Marie Siebke Troseid; Gunnstein Norheim; Yared Merid; Afework Kassu; Workeabeba Abebe; Samuel Ayele; Mezgebu Silamsaw Asres; Lawrence Yamuah; Abraham Aseffa; Beyene Petros; Dominique A Caugant; Petter Brandtzaeg
Journal:  Innate Immun       Date:  2019-04       Impact factor: 2.680

7.  Capsule-dependent impact of MAPK signalling on host cell invasion and immune response during infection of the choroid plexus epithelium by Neisseria meningitidis.

Authors:  Rosanna Herold; René Scholtysik; Selina Moroniak; Christel Weiss; Hiroshi Ishikawa; Horst Schroten; Christian Schwerk
Journal:  Fluids Barriers CNS       Date:  2021-12-04

8.  The causative pathogen determines the inflammatory profile in cerebrospinal fluid and outcome in patients with bacterial meningitis.

Authors:  Denis Grandgirard; Rahel Gäumann; Boubacar Coulibaly; Jean-Pierre Dangy; Ali Sie; Thomas Junghanss; Hans Schudel; Gerd Pluschke; Stephen L Leib
Journal:  Mediators Inflamm       Date:  2013-06-20       Impact factor: 4.711

Review 9.  Human genetics of meningococcal infections.

Authors:  Stephanie Hodeib; Jethro A Herberg; Michael Levin; Vanessa Sancho-Shimizu
Journal:  Hum Genet       Date:  2020-02-17       Impact factor: 4.132

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.